Our first breakthrough was the discovery of inborn errors in TLR3-dependent type I IFN production and response in patients with hypoxemic COVID-19 pneumonia, which showed that critical COVID-19 and influenza pneumonia can indeed be allelic (7). Here, TLR3 is linked to pneumonia.